Skip to main content
SpringerLink
Log in
Book cover

Obesity and its Impact on Health pp 149–166Cite as

Nanotechnology in the Context of Obesity

  • Chapter
  • First Online:

  • 538 Accesses

Abstract

Obesity is a pandemic disease with immense magnitude and it is due to escalating death with co-morbidity in this century. Obesity is caused by combinatorial factors including genetic, metabolic, behavioral, environmental, cultural, and socioeconomic factors that contribute to a person’s body weight. This condition parse is alarmingly big magnitude problem and it is conformingly with the co-morbidities. An elevated body mass index (BMI) increases the prevalence, morbidity, and mortality of type 2 diabetes mellitus, hypertension, heart disease, stroke, osteoarthritis, respiratory tract disorders, gallstones, certain types of cancer, and psychological disorders. It is striking that only a few therapeutic agents are available to treat obesity including orlistat, sibutramine, lorcaserin, phentermine-topiramate available to treat obesity. These agents can reduce body weight by decreasing the consumption or absorption of food or by augmenting energy disbursement. In recent decades, the limelight of nanotechnology has opened numerous new vistas in medical sciences, especially in the area of drug delivery. The nanoparticulate drug delivery system can transport specific anti-obesity drugs to the white adipose tissue in the body, aiding to evade potential side effects that can occur if the drugs find their way to other parts of the body. In this chapter, we highlighted the various nano-drug delivery systems including polymeric nanoparticles, chitosan nanoparticles, Polyethylene glycol-based nanoparticles, gold nanoparticles, liposomes, transfersomes, and microparticles to enhance the therapeutic efficacy against obesity treatment.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Ahmed AA, Hesham MT (2016) Metformin loaded carbopol gel for lowering the intra-abdominal visceral fat. J Bioequiv Availab 8: 149-152

    Google Scholar 

  • Araújo F, Shrestha N, Gomes MJ, Herranz-Blanco B, Liu D, Hirvonen JJ (2016) In vivo dual-delivery of glucagon like peptide-1 (GLP-1) and dipeptidyl peptidase-4 (DPP4) inhibitor through composites prepared by microfluidics for diabetes therapy. Nanoscale 8(20): 10706-10713

    Google Scholar 

  • Balada F, Sanchis D, Grasa MM, Virgili J, Estruch J, Fernández-López JA, Remesar X, Alemany M (1997) Effect of the slimming agent oleoyl-estrone in liposomes on the body weight of Zucker obese rats. Int J Obes Relat Metab Disord 21(9): 789-795

    Google Scholar 

  • Banks WA, DiPalma CR, Farrell CL (1999) Impaired transport of leptin across the blood-brain barrier in obesity. Peptides 20(11): 1341-1345

    Google Scholar 

  • Barnhart KF (2011) A peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys. Sci Transl Med 3(108): 108-112

    Google Scholar 

  • Berbari NF, Pasek RC, Malarkey EB (2013) Leptin resistance is a secondary consequence of the obesity in ciliopathy mutant mice. Proceedings of the National Academy of Sciences of the United States of America 110(19): 7796-7801

    Google Scholar 

  • Bin F, Ping J, Yaohui N, Thomas K, Dale J, Nico VR, Zaiqing Y, Haiyan Xu (2011) Clodronate liposomes improve metabolic profile and reduce visceral adipose macrophage content in diet-induced obese mice. PLoS One 6(9): e24358

    Google Scholar 

  • Boer AG, Gaillard PJ (2007) Drug targeting to the brain. Ann Rev Pharmacol Toxicol 47: 323-355

    Google Scholar 

  • Chandrasekaran CV, Vijayalakshmi MA, Prakash K, Bansal VS, Meenakshi J, Amit A (2012) Herbal approach for obesity management. Am J Plant Sci 3: 1003-1014

    Google Scholar 

  • Chawla A, Boisvert WA, Lee CH, Laffitte BA, Barak Y, Joseph SB, Liao D, Nagy L, Edwards PA, Curtiss LK (2001) A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol Cell 7: 161-171

    Google Scholar 

  • Cho EJ, Rahman MA, Kim SW, Baek YM, Hwang HJ, Oh JY, Hwang HS, Lee SH, Yun JW (2008) Chitosan oligosaccharides inhibit adipogenesis in 3T3-L1 adipocytes. J Microbiol Biotechnol 18: 80-87

    Google Scholar 

  • Chunhui J, Liangju K, Madeline PM, Feng Y, Mario AC, Naagarajan N, Shihuan K, Meng D (2015) Biodegradable polymeric microsphere-based drug delivery for inductive browning of fat. Front Endocrinol (Lausanne) 6: 169

    Google Scholar 

  • Colman E (2012) The FDA’s assessment of two drugs for chronic weight management. N Engl J Med 367(17): 1577-1579

    Google Scholar 

  • Cooke D, Bloom S (2006) The obesity pipeline: current strategies in the development of anti-obesity drugs. Nat Rev Drug Discov 5: 919-931

    Google Scholar 

  • Dowling RC, Grobert (2011) Nanoscience and nanotechnologies: opportunities and uncertainties. The Royal Society & The Royal Academy of Engineering Report, Royal Academy of Engineering, London, UK, 2004

    Google Scholar 

  • Dwivedi V, Shrivastava R, Hussain S, Ganguly C, Bharadwaj M (2011) Cytotoxic potential of Indian spices (extracts) against esophageal squamorimona carcinoma cells. Asian Pac J Cancer Prev 12(8): 2069-2073

    Google Scholar 

  • Ensign LM, Cone R, Hanes J (2012) Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers. Adv Drug Deliver Rev 64: 557-570

    Google Scholar 

  • Fathima A, Saravana Kumar P, Ramya Devi D, Vedha Hari BN (2012) Microparticulate drug delivery system of orlistat for sustained release. Int J Pharm Sci Rev Res 15(1): 27-30

    Google Scholar 

  • Fiona Moloney, Toh-Peng Yeow, Anne Mullen, John J Nolan, Helen M Roche (2004) Conjugated linoleic acid supplementation, insulin sensitivity, and lipoprotein metabolism in patients with type 2 diabetes mellitus. Am J Clin Nutr 80(4): 887-895

    Google Scholar 

  • Food and Drug Administration (FDA), Guidance for Industry: Assessing the Effects of Significant Manufacturing Process Changes, Including Emerging Technologies, on the Safety and Regulatory Status of Food Ingredients and Food Contact Substances, Including Food Ingredients That are Color Additives, Food and Drug Administration (FDA), Silver Spring, Md, USA, 2012

    Google Scholar 

  • Friedman JM (2009) Obesity: Causes and control of excess body fat. Nature 459(7245): 340-342

    Google Scholar 

  • Gabathuler R (2010) Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases. Neurobiol Dis 37: 48-57

    Google Scholar 

  • Gade MM, Hurkadale PJ (2016). Formulation and evaluation of self-emulsifying orlistat tablet to enhance drug release and in vivo performance: factorial design approach. Drug Deliv Transl Res 6(3): 276-288

    Google Scholar 

  • Göke R, Fehmann HC, Linn T, Schmidt H, Krause M (1993) Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of Insulin-secreting β-cells. J Biol Chem 268: 19650-19656

    Google Scholar 

  • Gupta BK, Manas Chakraborty, Debnath R, Soumyadip B, Nandy S (2010) Design and evaluation of rimonabant loaded sodium alginate-guar-gum microsphere formulation. IJPSR 1(8): 47-61

    Google Scholar 

  • Haas JS, Whipple RE, Grant PM, Andresen BD, Volpe AM, Pelkey GE (1997) Chemical and elemental comparison of two formulations of oleoresin capsicum. Sci Justice 37(1): 15-24

    Google Scholar 

  • Holst J (2007) The physiology of glucagon-like peptide 1. Physiol Rev 87: 1409-1439

    Google Scholar 

  • Hossen MN, Kajimoto K, Akita H, Hyodo M, Harashima H (2012) Vascular-targeted nanotherapy for obesity: unexpected passive targeting mechanism to obese fat for the enhancement of active drug delivery. J Control Release 28(2): 101-110. http://www.google.com.br/patents/US6541033; accessed on 16th September 2019

  • Dowman JK, Tomlinson JW, Newsome PN (2010) Pathogenesis of non-alcoholic fatty liver disease. QJM 103(2): 71-83

    Google Scholar 

  • Jamuna BA, Ravishankar RV (2019) Nanoemulsions and their potential applications in food industry. Front Sustain Food Syst 13(3): 1-21

    Google Scholar 

  • Jeon G, Choi Y, Lee SM, Kim Y, Jeong HS, Lee J (2010) Anti-obesity activity of methanol extract from hot pepper (Capsicum annuum L.) seeds in 3T3-L1 adipocyte. Food Sci Biotechnol 19(4): 1123-1127

    Google Scholar 

  • Joo-Yeon K, Mak-Soon L, Sunyoon J, Hyunjin J, Chong-Tai K, In-Hwan K, Sangjin S, Soojung O, Yangha K (2014) Anti-obesity efficacy of nanoemulsion oleoresin capsicum in obese rats fed a high-fat diet. Int J Nanomedicine 9: 301-310

    Google Scholar 

  • Joseph R, Elliot LF (1997) LIPOSOME FORMULATIONS OF 5β STEROIDS WO 1997013500 A2 Application no: PCT/US1996/015507

    Google Scholar 

  • Jyotibala B (2017) Application of nanotechnology in food technology and targeted drug therapy for prevention of obesity: An overview. J Crit Rev 4(1): 7-11

    Google Scholar 

  • Kristina Martinez, Arion Kennedy, Tiffany West, Dejan Milatovic, Michael Aschner, Michael McIntosh (2010) J Biol Chem 285 (23): 17701-17712

    Google Scholar 

  • Kumar SG, Rahman MA, Lee SH, Hwang HS, Kim H, Yun JW (2009) Plasma proteome analysis for anti-obesity and anti-diabetic potentials of chitosan oligosaccharides in ob/ob mice. Proteomics 9: 2149-2162

    Google Scholar 

  • Kumari A, Yadav SK, Yadav SC (2010) Biodegradable polymeric nanoparticles based drug delivery systems. Colloids and surfaces B: Biointerfaces 75(1): 1-8

    Google Scholar 

  • Kun L, Shuanshuan X, Shilong H, Jidong Z, Xinwen C, Jin C, Qingqing H, Qing Y, Haiyan L, Lei X (2014) Preparation of a nano emodin transfersome and study on its anti-obesity mechanism in adipose tissue of diet-induced obese rats. J Transl Med 12: 72

    Google Scholar 

  • Lanlan H, Jian C, Peiqiu C, Haitao P, Chen D, Tiancun X, Pengfei Z, Jiao G, Zhengquan S (2015) Anti-obese effect of glucosamine and chitosan oligosaccharide in high-fat diet-induced obese rats. Mar Drugs 13: 2732-2756

    Google Scholar 

  • Lichota J, Skjorringe T, Thomsen LB, Moos T (2010) Macromolecular drug transport into the brain using targeted therapy. J Neurochem 113: 1-13

    Google Scholar 

  • Khazaei M, Tahergorabi Z (2013) Systemic ghrelin administration alters serum biomarkers of angiogenesis in diet-induced obese mice Int J Pept ID 249565: 5

    Google Scholar 

  • Madureira AR, Pereira A, Pintado M (2015) Current state on the development of nanoparticles for use against bacterial gastrointestinal pathogens. Focus on chitosan nanoparticles loaded with phenolic compounds. Carbohydr Polym 130: 429-439

    Google Scholar 

  • Margalit R, Yerushalmi N (2005) Pharmaceutical aspects of liposomes: academic and industrial research and development. Microencapsulation Methods and Industrial Applications 1: 317-344

    Google Scholar 

  • Meltem C, Selma S (2016) Microparticulate and nanoparticulate drug delivery systems for metformin hydrochloride. Drug Deliv 23(8): 2796-2805

    Google Scholar 

  • National Center for Health Statistics, Hyattsville, Md (1999) Prevalence of overweight or obesity among adults: United States. Health E-Stats 2000

    Google Scholar 

  • Nazarii K, Ludovico A, Tetyana F, Oleksandr V, Belemets N, Tetyana B, Petro B, Mykola S (2016) Prevention of NAFLD development in rats with obesity via the improvement of pro/antioxidant state by cerium dioxide nanoparticles. Clujul Med 89(2): 229-235

    Google Scholar 

  • Overweight, obesity, and health risk (2000) National task force on the prevention and treatment of obesity. Arch Intern Med 160: 898-904

    Google Scholar 

  • Padwal RS, Majumdar SR (2007) Drug treatments for obesity: orlistat, sibutramine, and rimonabant. Lancet 369: 71-77

    Google Scholar 

  • Rahman A, Kumar SG, Kim SW, Hwang HJ, Baek YM, Lee SH, Hwang HS, Shon YH, Nam KS, Yun JW (2008) Proteomic analysis for inhibitory effect of chitosan oligosaccharides on 3T3-L1 adipocyte differentiation. Proteomics 8: 569-581

    Google Scholar 

  • Reinbach, H C, Smeets A, Martinussen T, Møller P, Westerterp‐Plantenga, MS (2009) Effects of capsaicin, green tea and CH‐19 sweet pepper on appetite and energy intake in humans in negative and positive energy balance. Clinical Nutrition 28(3): 260-265

    Google Scholar 

  • Sargent, BJ, Moore NA (2009) New central targets for the treatment of obesity. Br J Clin Pharmacol 68: 852-860

    Google Scholar 

  • Shikha J, Vikas J, Mahajan SC (2014) Lipid based vesicular drug delivery systems. Adv Pharm Article ID 574673: 12

    Google Scholar 

  • Singer K, Morris DL, Oatmen KE (2013) Neuropeptide Y is produced by adipose tissue macrophages and regulates obesity-induced inflammation. PLoS One 8(3): e57929

    Google Scholar 

  • Sung HW, Sonaje K, Liao ZX, Hsu LW, Chuang EY (2012) pH-responsive nanoparticles shelled with chitosan for oral delivery of insulin: from mechanism to therapeutic applications. Acc Chem Res 45: 619-629

    Google Scholar 

  • Sunil KJ, Govind PA, Narendra KJ (2006) Evaluation of porous carrier-based floating orlistat microspheres for gastric delivery AAPS Pharm Sci Tech 7(4): E54-E62

  • Tan S, Gao B, Tao Y, Guo J, Su ZQ (2014) Anti-obese effects of capsaicin-chitosan microsphere (CCMS) in obese rats induced by high fat diet. J Agric Food Chem 62(8): 1866-1874

    Google Scholar 

  • Tiwari SB, Amiji MM (2006) A review of nanocarrier-based CNS delivery systems. Curr Drug Deliv 3: 219-232

    Google Scholar 

  • Toita R, Kawano T, Murata M, Kang JH (2016) Anti-obesity and anti-inflammatory effects of macrophage-targeted interleukin-10-conjugated liposomes in obese mice. Biomaterials 110: 81-88

    Google Scholar 

  • Thovhogi N, Sibuyi N, Meyer M, Onani M, Madiehe A (2015) Targeted delivery using peptide-functionalised gold nanoparticles to white adipose tissues of obese rats. J Nanopart Res 17(2): 112

    Google Scholar 

  • Tosi G, Bortot B, Ruozi B, (2013) Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier. Curr Med Chem 20: 2212-2225

    Google Scholar 

  • Tosi G, Costantino L, Rivasi F (2007) Targeting the central nervous system: in vivo experiments with peptide-derivatized nanoparticles loaded with loperamide and rhodamine-123. J Control Release 122: 1-9

    Google Scholar 

  • Tuerk C, Gold L (1990) Systemic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerage. Science 249: 505-510

    Google Scholar 

  • US 20150190531 A1 Nanoparticle delivery system for targeted anti-obesity treatment

    Google Scholar 

  • US Department of Health and Human Services. The Surgeon General’s Call to Action to Prevent and Decrease Overweight and Obesity. Washington, DC, 2004

    Google Scholar 

  • Van Heek M, Compton DS, France CF, Tedesco RP, Fawzi AB, Graziano MP, Sybertz EJ., Strader CD, Davis HR (1997) Diet-induced obese mice develop peripheral, but not central, resistance to leptin. J Clin Investig 99: 385-390

    Google Scholar 

  • Zhang XZ, Guan J, Cai SL, Du Q, Guo ML (2015) Polymeric in situ hydrogel implant of epigallocatechin gallate (EGCG) for prolonged and improved antihyperlipidemic and anti-obesity activity: preparation and characterization. J Biomater Tissue Eng 5(10): 813-817

    Google Scholar 

  • Zimmer AR, Leonardi B, Miron D, Schapoval E, Oliveira JR, Gosmann G (2012) Antioxidant and anti-inflammatory properties of Capsicum baccatum: from traditional use to scientific approach. J Ethnopharmacol 139(1): 228-233

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmaceutics, Faculty of Pharmacy, Lincoln University College, Petaling Jaya, Malaysia

    Satheesh Babu Natarajan

  2. Department of Biochemistry, Faculty of Medicine, Lincoln University College, Petaling Jaya, Malaysia

    Suriyakala Perumal Chandran

  3. Department of Pathology, Faculty of Medicine, Lincoln University College, Petaling Jaya, Selangor, Malaysia

    Methil Kannan Kutty

Authors
  1. Satheesh Babu Natarajan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Suriyakala Perumal Chandran
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Methil Kannan Kutty
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Pathology, Faculty of Medicine, Lincoln University College, Petaling Jaya, Selangor, Malaysia

    Methil Kannan Kutty

  2. Biotechnology Department, Faculty of Science, Lincoln University College, Petaling Jaya, Selangor, Malaysia

    Asita Elengoe

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Natarajan, S.B., Perumal Chandran, S., Kutty, M.K. (2021). Nanotechnology in the Context of Obesity. In: Kutty, M.K., Elengoe, A. (eds) Obesity and its Impact on Health. Springer, Singapore. https://doi.org/10.1007/978-981-33-6408-0_11

Download citation

Publish with us

Policies and ethics

Search

Navigation